SOLARA ACTIVE PHARMA SCIENCES
Back to Balance Sheet
|
SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹172 Cr | ₹217 Cr | ₹299 Cr | ₹206 Cr | ₹333 Cr |
What is the latest Total Non-Current Liabilities ratio of SOLARA ACTIVE PHARMA SCIENCES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹172 Cr |
Mar2023 | ₹217 Cr |
Mar2022 | ₹299 Cr |
Mar2021 | ₹206 Cr |
Mar2020 | ₹333 Cr |
How is Total Non-Current Liabilities of SOLARA ACTIVE PHARMA SCIENCES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹172 Cr | -21.00 | |
Mar2023 | ₹217 Cr | -27.43 | |
Mar2022 | ₹299 Cr | 44.93 | |
Mar2021 | ₹206 Cr | -38.06 | |
Mar2020 | ₹333 Cr | - |
Compare Total Non-Current Liabilities of peers of SOLARA ACTIVE PHARMA SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SOLARA ACTIVE PHARMA SCIENCES | ₹3,245.5 Cr | 8% | 33.1% | 6.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SOLARA ACTIVE PHARMA SCIENCES | 8% |
33.1% |
6.9% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses